MedPath

Pain Severity in Flapless Dental Implant Placement Using Laser

Phase 4
Completed
Conditions
Jaw, Edentulous, Partially
Interventions
Device: Laser-induced Incision
Procedure: Punch Incision
Procedure: Implant Placement
Registration Number
NCT06294249
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

The goal of this split-mouth randomized clinical trial study was to investigate the effect of using a laser on pain and discomfort following flapless dental implant surgery. It was hypothesized that laser did not have any impact on post-op pain. Therefore, the study aimed to compare pain and discomfort following flapless dental implant surgeries with or without a laser.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  1. Adult human subjects agreed to participate in the study and return on follow-up times
  2. Subjects eligible for receiving dental implants
  3. Subjects with an edentulous area in the posterior of the mandible bilaterally 3- Subjects with sufficient bone width and height (>5 mm width, and >10 mm height) at the implant sites
  4. Subjects with sufficient keratinization tissue at the implant sites
Exclusion Criteria
  1. Subjects refused to return for follow-up or refused study enrollment.
  2. Subjects with uncontrolled systemic diseases
  3. Subjects younger than 18 years
  4. Subjects receiving psychotropic drugs

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Laser-induced IncisionLaser-induced IncisionThe Biolase Epic 10 diode laser device (Biolase, USA) with 940 nm wavelength, 10 W of max output power, 20 KHz of pulse repetition rate, and continuous pulse mode was used.
Punch IncisionImplant PlacementThe soft tissue Osstem punch (South Korea) was used.
Punch IncisionPunch IncisionThe soft tissue Osstem punch (South Korea) was used.
Laser-induced IncisionImplant PlacementThe Biolase Epic 10 diode laser device (Biolase, USA) with 940 nm wavelength, 10 W of max output power, 20 KHz of pulse repetition rate, and continuous pulse mode was used.
Primary Outcome Measures
NameTimeMethod
Pain SeverityPatients were visited at 24, 48, 72 hours, and 7 days after insertion.

Measured using the visual analogue scale (VAS): 0-3 mild pain, 4-6 moderate pain, and 7-10 sever pain.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

shiraz University of medical sciences

🇮🇷

Shiraz, Fars, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath